Shelter Pharma Limited (BOM:543963)
India · Delayed Price · Currency is INR 42.65
-0.25 (-0.58%)
At close: Oct 27, 2025
Shelter Pharma Revenue
In the fiscal year ending March 31, 2025, Shelter Pharma had annual revenue of 506.60M INR with 26.58% growth. Shelter Pharma had revenue of 266.03M in the half year ending March 31, 2025, with 39.03% growth.
Revenue
506.60M
Revenue Growth
+26.58%
P/S Ratio
1.25
Revenue / Employee
7.34M
Employees
69
Market Cap
633.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 506.60M | 106.37M | 26.58% |
| Mar 31, 2024 | 400.23M | 38.70M | 10.70% |
| Mar 31, 2023 | 361.53M | 60.97M | 20.29% |
| Mar 31, 2022 | 300.56M | 75.72M | 33.68% |
| Mar 31, 2021 | 224.83M | -75.82M | -25.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.69T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |